These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 15558283)
1. The place of cladribine in the treatment of chronic lymphocytic leukemia: a 10-year experience in Poland. Robak T Ann Hematol; 2005 Feb; 84(2):63-70. PubMed ID: 15558283 [TBL] [Abstract][Full Text] [Related]
2. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia. Robak T; Lech-Maranda E; Robak P Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624 [TBL] [Abstract][Full Text] [Related]
3. Recent progress in the management of chronic lymphocytic leukemia. Robak T Cancer Treat Rev; 2007 Dec; 33(8):710-28. PubMed ID: 17904294 [TBL] [Abstract][Full Text] [Related]
4. Comparison of cladribine plus prednisone with chlorambucil plus prednisone in patients with chronic lymphocytic leukemia. Final report of the Polish Adult Leukemia Group (PALG CLL1). Robak T; Błoński JZ; Kasznicki M; Góra-Tybor J; Dmoszyńska A; Wojtaszko M; Skotnicki AB; Nowak W; Hellmann A; Lewandowski K; Zdziarska B; Konopka L; Ceglarek B; Dwilewicz-Trojaczek J; Boguradzki P; Kuliczkowski K; Sułek K; Warzocha K Med Sci Monit; 2005 Oct; 11(10):PI71-9. PubMed ID: 16192912 [TBL] [Abstract][Full Text] [Related]
5. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia. Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052 [TBL] [Abstract][Full Text] [Related]
6. Comparison of cladribine plus cyclophosphamide with fludarabine plus cyclophosphamide as first-line therapy for chronic lymphocytic leukemia: a phase III randomized study by the Polish Adult Leukemia Group (PALG-CLL3 Study). Robak T; Jamroziak K; Gora-Tybor J; Stella-Holowiecka B; Konopka L; Ceglarek B; Warzocha K; Seferynska I; Piszcz J; Calbecka M; Kostyra A; Dwilewicz-Trojaczek J; Dmoszyñska A; Zawilska K; Hellmann A; Zdunczyk A; Potoczek S; Piotrowska M; Lewandowski K; Blonski JZ J Clin Oncol; 2010 Apr; 28(11):1863-9. PubMed ID: 20212251 [TBL] [Abstract][Full Text] [Related]
7. Rituximab plus cladribine with or without cyclophosphamide in patients with relapsed or refractory chronic lymphocytic leukemia. Robak T; Smolewski P; Cebula B; Grzybowska-Izydorczyk O; Błoński JZ Eur J Haematol; 2007 Aug; 79(2):107-13. PubMed ID: 17635235 [TBL] [Abstract][Full Text] [Related]
8. Activity of cladribine combined with cyclophosphamide in frontline therapy for chronic lymphocytic leukemia with 17p13.1/TP53 deletion: report from the Polish Adult Leukemia Group. Robak T; Blonski JZ; Wawrzyniak E; Gora-Tybor J; Palacz A; Dmoszynska A; Konopka L; Warzocha K; Jamroziak K Cancer; 2009 Jan; 115(1):94-100. PubMed ID: 19025975 [TBL] [Abstract][Full Text] [Related]
9. In vitro sensitivity of chronic lymphocytic leukemia B-cells to fludarabine, 2-chlorodeoxyadenosine and chlorambucil: correlation with clinico-hematological and immunophenotypic features. Morabito F; Stelitano C; Callea I; Filangeri M; Oliva B; Sculli G; Callea V; Nobile F; Brugiatelli M Haematologica; 1996; 81(3):224-31. PubMed ID: 8767527 [TBL] [Abstract][Full Text] [Related]
10. A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia. Hillmen P; Cohen DR; Cocks K; Pettitt A; Sayala HA; Rawstron AC; Kennedy DB; Fegan C; Milligan DW; Radford J; Mercieca J; Dearden C; Ezekwisili R; Smith AF; Brown J; Booth GA; Varghese AM; Pocock C; Br J Haematol; 2011 Mar; 152(5):570-8. PubMed ID: 21231927 [TBL] [Abstract][Full Text] [Related]
11. 2-Chlorodeoxyadenosine (2-CdA) in the treatment of patients with relapsed chronic lymphocytic leukemia. Krykowski E; Warzocha K; Robak T Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):317-21. PubMed ID: 8744653 [TBL] [Abstract][Full Text] [Related]
12. Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997. Flinn IW; Neuberg DS; Grever MR; Dewald GW; Bennett JM; Paietta EM; Hussein MA; Appelbaum FR; Larson RA; Moore DF; Tallman MS J Clin Oncol; 2007 Mar; 25(7):793-8. PubMed ID: 17283364 [TBL] [Abstract][Full Text] [Related]
13. Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma. Robak T; Smolewski P; Cebula B; Szmigielska-Kaplon A; Chojnowski K; Blonski JZ Cancer; 2006 Oct; 107(7):1542-50. PubMed ID: 16948126 [TBL] [Abstract][Full Text] [Related]
14. Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of a prospective, multicenter, randomized trial of the Polish Adult Leukemia Group (PALG CLL2). Robak T; Blonski JZ; Gora-Tybor J; Jamroziak K; Dwilewicz-Trojaczek J; Tomaszewska A; Konopka L; Ceglarek B; Dmoszynska A; Kowal M; Kloczko J; Stella-Holowiecka B; Sulek K; Calbecka M; Zawilska K; Kuliczkowski K; Skotnicki AB; Warzocha K; Kasznicki M; Blood; 2006 Jul; 108(2):473-9. PubMed ID: 16551966 [TBL] [Abstract][Full Text] [Related]
15. Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies. Robak T Transfus Apher Sci; 2005 Feb; 32(1):33-44. PubMed ID: 15737872 [TBL] [Abstract][Full Text] [Related]
16. Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies. Mohammad RM; Katato K; Almatchy VP; Wall N; Liu KZ; Schultz CP; Mantsch HH; Varterasian M; al-Katib AM Clin Cancer Res; 1998 Feb; 4(2):445-53. PubMed ID: 9516935 [TBL] [Abstract][Full Text] [Related]
17. Cladribine in the treatment of chronic lymphocytic leukemia. Robak T Leuk Lymphoma; 2001 Feb; 40(5-6):551-64. PubMed ID: 11426528 [TBL] [Abstract][Full Text] [Related]
18. Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia. Robak T; Kasznicki M Leukemia; 2002 Jun; 16(6):1015-27. PubMed ID: 12040433 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of apoptosis induced in vitro by cladribine (2-CdA) combined with anthracyclines in lymphocytes from patients with B-cell chronic lymphocytic leukemia. Szmigielska-Kaplon A; Smolewski P; Najder M; Robak T Ann Hematol; 2002 Sep; 81(9):508-13. PubMed ID: 12373351 [TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of cladribine alone or in combination with cyclophosphamide, and cyclophosphamide, vincristine and prednisone in previously untreated low-grade B-cell non-Hodgkin lymphoma patients: final report of the Polish Lymphoma Research Group. Kalinka-Warzocha E; Wajs J; Lech-Maranda E; Ceglarek B; Holowiecki J; Federowicz I; Walewski J; Czyz J; Robak T; Warzocha K; Cancer; 2008 Jul; 113(2):367-75. PubMed ID: 18470902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]